Category Archives: Featured Article

Pioneering scheme set to launch in Norwich to create ‘rapid response’ community health and social worker teams

Your Norwich aims to transform health and social care in Norwich.

Adam Gretton Health correspondent adam.gretton@archant.co.uk
Saturday, May 31, 2014
6:30 AM

A pioneering scheme to create “rapid response” teams of community health and social workers is set to be unveiled in Norwich, which aims to improve the care of hundreds of vulnerable patients.

The GP-led group in charge of NHS purse strings in the city has pledged to plough £16m into the scheme over the next two years to integrate health and care services to help provide better treatment and support for people in their own homes and avoid unnecessary hospital admissions.

Dementia beds and staffing in Norfolk and Suffolk cut by 45pc ahead of looming increase in cases

Former Waveney MP, Bob Blizzard speaking at a rally

Former Waveney MP, Bob Blizzard speaking at a rally to sending a message to the government and the Norfolk and Suffolk Foundation Trust to think again on proposals for cuts to local mental health care services. Picture: James Bass

Thursday, May 29, 2014
6:30 AM

Mental health bosses have warned that Norfolk and Suffolk does not have the capacity to cope with a looming increase in dementia cases after beds and staffing numbers were cut by 45pc.

Changing dementia care in Norfolk and Suffolk

NHS patients to get new MS drug

  • Treatment not only stops the disease from advancing but may help patients recover from disability
  • Scientists have spent 25 years developing treatment at Cambridge
  • Alemtuzumab infusion is given in two short courses over two years
  • Despite costing £56,000, NICE has ruled treatment is cost-effective

By Jenny Hope

 

article-2641144-1E4257D500000578-996_306x423

A new treatment for Multiple Sclerosis not only stops the disease from advancing but may help patients recover from disability.

Remarkable results for the drug alemtuzumab mean it has been approved for use on the NHS and is now available in England.

Originally a pioneering cancer therapy, Cambridge University scientists have spent almost 25 years developing it as a treatment for MS sufferers.

Trials involving more than 1,500 patients show treatment led to fewer relapses compared with multiple jabs of the treatment beta interferon each week, cutting further disability and even allowing some existing damage to recover.